Patents by Inventor Mohamed G. Shoreibah

Mohamed G. Shoreibah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • N-acetylglucosaminyltransferase V proteins and coding sequences
    Patent number: 6015701
    Abstract: The present invention provides substantially purified UDP-N-acetylglucosamine: .alpha.-6-D-mannoside .beta.-1,6-N-acetylglucosaminyl transferase (GlcNAc T-V; EC 2.4.1.155) proteins and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by GlcNAc T-V coding sequences from rat, hamster, mouse and human.
    Type: Grant
    Filed: July 19, 1994
    Date of Patent: January 18, 2000
    Assignees: University of Georgia Research Foundation, Inc., Amgen, Inc.
    Inventors: James Michael Pierce, Mohamed G. Shoreibah, Beverly Adler, Nevis Lee Fregien
  • N-acetylglucosaminyltransferase V gene
    Patent number: 5602003
    Abstract: The present invention provides a substantially purified UDP-N-acetylglucosamine:.alpha.-6-D-mannoside .beta.-1,6-N-acetylglucosaminyltransferase (GlcNAc T-V; EC 2.4.1.155) and antibodies which specifically bind GlcNAc T-V. The present invention also provides polynucleotide sequences and oligonucleotide probes capable of specifically hybridizing to nucleic acid sequences which encode GlcNAc T-V, and cDNA and genomic clones encoding GlcNAc T-V, as well as nucleotide sequences encoding GlcNAc T-V, as specifically exemplified by a GlcNAc T-V coding sequence from rat.
    Type: Grant
    Filed: February 10, 1993
    Date of Patent: February 11, 1997
    Assignee: University of Georgia Research Foundation
    Inventors: J. Michael Pierce, Mohamed G. Shoreibah, Beverly S. Adler, Nevis L. Fregien